Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

HTLV-1 infections.

¹Department of Immunology, Imperial College School of Medicine, London, UK. c.bangham@ic.ac.uk

Journal of Clinical Pathology

|September 26, 2000

Summary

Human T lymphotropic virus type 1 (HTLV-1) infection can lead to severe diseases. Understanding the host immune response is key to predicting disease risk and developing treatments for HTLV-1 and similar persistent viral infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells.

Blood·2001

Same author

Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1.

Proceedings. Biological sciences·2001

Same author

Selection forces and constraints on retroviral sequence variation.

Science (New York, N.Y.)·2001

Same author

Is human T-cell lymphotropic virus type I really silent?

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2001

Same author

AIDS: the evolving story.

Trends in microbiology·2001

Same author

In vivo selection of T-cell receptor junctional region sequences by HLA-A2 human T-cell lymphotropic virus type 1 Tax11-19 peptide complexes.

Journal of virology·2001

Area of Science:

Virology
Immunology
Infectious Diseases

Background:

Human T lymphotropic virus type 1 (HTLV-1) is a significant human pathogen responsible for severe and fatal diseases.
Currently, there are no effective vaccines, treatments, or reliable methods for predicting disease progression or prognosis in individuals infected with HTLV-1.

Purpose of the Study:

To investigate the role of the host immune response in the pathogenesis of HTLV-1 associated diseases.
To elucidate the mechanisms underlying the differential outcomes of HTLV-1 infection, distinguishing between healthy carriers and those who develop severe illnesses.

Main Methods:

Analysis of molecular virology and immunology data related to HTLV-1 infection.
Comparative studies of immune responses in HTLV-1 infected individuals with varying clinical outcomes.

Main Results:

Recent research highlights the critical role of the host immune system in mitigating the risk of HTLV-1 associated diseases.
The study begins to explain the immunological factors that determine whether an HTLV-1 infected individual develops severe illness or remains aymptomatic.

Conclusions:

Host immune response is a crucial determinant of disease development in HTLV-1 infection.
Findings may inform strategies for managing other persistent viral infections, including HIV, HBV, and HCV.

Related Experiment Videos